Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
===========================================================================================================================================

* Amy K. Erbe
* Wei Wang
* Lakeesha Carmichael
* Anna Hoefges
* Bartosz Grzywacz
* Patrick K. Reville
* Erik A. Ranheim
* Jacquelyn A. Hank
* KyungMann Kim
* Songwon Seo
* Eneida A. Mendonca
* Yiqiang Song
* Vaishalee P. Kenkre
* Fangxin Hong
* Randy D. Gascoyne
* Elisabeth Paietta
* Sandra J. Horning
* Jeffrey S. Miller
* Brad Kahl
* Paul M. Sondel